Inogen (INGN) Posts Q4 Loss of $0.03, Revs Beat; Outlook Raised
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Inogen, Inc (INGN) PT Raised to $150 at Needham & Company; Domestic B2B and DTC Sales Drive Results
February 28, 2018 7:17 AM ESTNeedham & Company raised its price target on Inogen, Inc (NASDAQ: INGN) to $150.00 (from $125.00) while maintaining a Strong Buy rating.
Analyst Mike Matson commented, "INGN beat consensus revenue, EBITDA, and EPS in 4Q17. Management raised its 2018 revenue and net income guidance and maintained its... More
